Back to Search
CARA SWEENEY, MD
MD
Internal Medicine Physician
NPI: 1952788739IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
297846(NY)287411(MA)
Pediatrics Physician
Pediatrics
Code: 208000000X
297846(NY)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE
Class of 2015
Research & Publications (20)
Growth factor-specific signaling pathway stimulation and gene expression mediated by ErbB receptors.
PMID 11297548·J Biol Chem·2001
7-preclinical
Ligand discrimination in signaling through an ErbB4 receptor homodimer.
PMID 10867024·J Biol Chem·2000
8-other
Ligand discrimination by ErbB receptors: differential signaling through differential phosphorylation site usage.
PMID 11114736·Oncogene·2000
6-review
Optical properties of anisotropic core-shell pyramidal particles.
PMID 19290590·J Phys Chem A·2009
8-other
Does surgery have a role in management of chronic intrascrotal pain?
PMID 18436286·Urology·2008
8-other
A phase II multicenter, randomized, double-blind, safety trial assessing the pharmacokinetics, pharmacodynamics, and efficacy of oral 2-methoxyestradiol capsules in hormone-refractory prostate cancer.
PMID 16166441·Clin Cancer Res·2005
3-trial
The role of neuronal nitric oxide in the vagal control of cardiac interval of the rat heart in vitro.
PMID 15182740·Auton Neurosci·2004
7-preclinical
The current status of sports medicine training in United States internal medicine residency programmes.
PMID 12782546·Br J Sports Med·2003
8-other
Trimetrexate inhibits progression of the murine 32Dp210 model of chronic myeloid leukemia in animals expressing drug-resistant dihydrofolate reductase.
PMID 12649191·Cancer Res·2003
7-preclinical
Methotrexate exacerbates tumor progression in a murine model of chronic myeloid leukemia.
PMID 11861818·J Pharmacol Exp Ther·2002
7-preclinical
Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: a Phase II trial in patients with metastatic nonsmall cell lung carcinoma .
PMID 11745199·Cancer·2001
3-trial
Combination nicotine replacement therapy for smoking cessation: rationale, efficacy and tolerability.
PMID 11524024·CNS Drugs·2001
6-review
Results and outcome of retroperitoneal lymph node dissection for clinical stage I embryonal carcinoma--predominant testis cancer.
PMID 10637250·J Clin Oncol·2000
8-other
Demonstration of high-precision continuous measurements of water vapor isotopologues in laboratory and remote field deployments using wavelength-scanned cavity ring-down spectroscopy (WS-CRDS) technology.
PMID 19603459·Rapid Commun Mass Spectrom·2009
8-other
A phase II study of pemetrexed as second-line chemotherapy for the treatment of metastatic castrate-resistant prostate cancer (CRPC); Hoosier Oncology Group GU03-67.
PMID 19605506·Ann Oncol·2009
3-trial
Relation of body fat indexes to vitamin D status and deficiency among obese adolescents.
PMID 19640956·Am J Clin Nutr·2009
8-other
A comparison of colon and rectal somatic DNA alterations.
PMID 19571709·Dis Colon Rectum·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 330 BROOKLINE AVE
BOSTON, MA 02215 - Phone
- (617) 667-7000
Quick Facts
- NPI
- 1952788739
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 3
- Years in Practice
- 11
- Publications
- 20
Are you this provider?
Claim Your Profile